09.11.2023 • News • Arkema • Thierry Le Henaff • People

Arkema to Extend Thierry Le Hénaff’s Contract as Chairman and CEO

Arkema board of directors has unanimously expressed its confidence in the company’s chairman and CEO Thierry Le Hénaff to execute the strategy announced during Arkema’s capital markets day on Sep. 27 and proposed the renewal of his term of office for four years at the company’s next annual shareholders meeting in May 2024.

The proposal is subject to approval by the company’s shareholders, Arkema said, adding that the board highlighted the “successful transformation of Arkema into a specialty materials player” in its decision to propose the renewal of Le Hénaff’s term of office as Arkema’s chairman and CEO.

Thierry Le Hénaff, Chairman and CEO, Arkema. © Bruno Mazodier/Arkema
Thierry Le Hénaff, Chairman and CEO, Arkema. © Bruno Mazodier/Arkema

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature